Company
Headquarters: Tokyo, Japan
Employees: 3,696
CEO: Mr. Taisuke Murai
¥53.23 Billion
JPY as of Jan. 1, 2024
US$378.0 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $63.92 B |
| Cencora, Inc. | $43.41 B |
| Cardinal Health, Inc. | $26.02 B |
| Henry Schein, Inc. | $9.72 B |
| Sinopharm Group Co. Ltd | $8.04 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Vital KSK Holdings, Inc. has the following listings and related stock indices.
Stock: JPX: 3151 wb_incandescent
Stock: OTC: VKSKF wb_incandescent